XML 25 R9.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Statement Of Cash Flows [Abstract]      
Net earnings available to common stockholders from continuing operations $ 335.4 $ 258.1 [1],[2] $ 95.3 [1]
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities      
Depreciation and amortization 213.3 266.7 [1],[2] 283.4 [1]
Share-based incentive compensation [3] 61.2 54.1 [1],[2] 24.1 [1]
Profit sharing expense 36.0 36.7 [1],[2] 34.7 [1]
Loss on debt redemption and refinancing activities 110.0 102.5 [1],[2] 36.3 [1]
Remeasurement loss related to Venezuelan subsidiaries 33.1 20.4 [1],[2] 13.1 [1]
Development grant matter [1],[2]   14.0  
Impairment of equity method investment [1]   5.7 [2] 2.1
Asset impairment [1],[2]   4.0  
Provisions for bad debt 5.8 8.0 [1],[2] 11.6 [1]
Provisions (recovery) for inventory obsolescence (0.2) 9.2 [1],[2] (0.3) [1]
Gain from Claims Settlement [1],[2]   (21.1)  
Deferred taxes, net (22.6) 146.2 [1],[2] 3.8 [1]
Excess tax benefit from Common Stock issued in the Settlement agreement [4] (46.2) (37.7) [1],[2]  
Excess tax benefit from stock based compensation (13.1)    
Net (gain) loss on disposals of property and equipment and other (3.3) 0.8 [1],[2] (1.4) [1]
Gain on sale of business (24.6)    
Other non-cash items, net 4.9 0.4 [1],[2] 33.1 [1]
Changes in operating assets and liabilities:      
Trade receivables, net 36.7 (27.8) [1],[2] 35.5 [1]
Inventories (38.3) (48.7) [1],[2] 22.0 [1]
Accounts payable 81.3 146.5 [1],[2] 36.3 [1]
Income tax receivable 32.2 (214.6) [1],[2] (22.5) [1]
Settlement agreement and related items [4] 235.2 (929.7) [1],[2] 48.2 [1]
Other assets and liabilities (69.1) (8.4) [1],[2] (14.9) [1]
Net cash provided by (used in) operating activities 967.7 (214.7) [1],[2] 640.4 [1]
Cash flows from investing activities:      
Capital expenditures (184.0) (153.9) [1],[2] (116.0) [1]
Proceeds from sale of business 94.6    
Businesses acquired in purchase transactions, net of cash and cash equivalents acquired (27.5) (3.6) [1],[2] (1.0) [1]
Proceeds from sales of property, equipment and other assets 32.9 16.1 [1],[2] 11.6 [1]
Settlement of foreign currency forward contracts 24.0 15.1 [1],[2] (8.5) [1]
Net cash used in investing activities (60.0) (126.3) [1],[2] (113.9) [1]
Cash flows from financing activities:      
Net proceeds from short-term borrowings 111.3 72.7 [1],[2] 53.2 [1]
Cash used as collateral on borrowing arrangements (20.3) (36.2) [1],[2]  
Proceeds from long-term debt 855.0 2,282.6 [1],[2] 425.1 [1]
Payments of long-term debt (754.3) (2,290.6) [1],[2] (658.3) [1]
Excess tax benefit from Common Stock issued in the Settlement agreement 46.2 37.7 [1],[2]  
Excess tax benefit from stock based compensation 13.1   (0.1) [1]
Dividends paid on common stock (106.8) (110.9) [1],[2] (102.0) [1]
Repurchases of common stock (802.0) (184.0) [1],[2]  
Payments for debt issuance costs (8.8) (24.3) [1],[2] (7.7) [1]
Payments for debt extinguishment costs (99.4) (74.7) [1],[2] (26.2) [1]
Other financing activities (9.3) 0.1 [1],[2] (3.9) [1]
Net cash used in financing activities (775.3) (327.6) [1],[2] (319.9) [1]
Effect of foreign currency exchange rate changes on cash and cash equivalents (60.4) (37.4) [1],[2] (20.8) [1]
Net change in cash and cash equivalents from continuing operations 72.0 (706.0) [1],[2] 185.8 [1]
Net cash provided by operating activities from discontinued operations [1]     6.4
Net cash provided by investing activities from discontinued operations [1]     120.6
Net change in cash and cash equivalents from discontinued operations [1]     127.0
Balance, beginning of period [1] 286.4 [2],[5],[6],[7] 992.4 [2] 679.6
Net change during the period 72.0 (706.0) [1],[2] 312.8 [1]
Balance, end of period 358.4 286.4 [1],[2],[5],[6],[7] 992.4 [1],[2]
Supplemental Cash Flow Information:      
Interest payments, net of amounts capitalized 229.7 710.4 [1],[2] 289.7 [1]
Income tax payments 101.6 85.1 [1],[2] 114.8 [1]
Stock appreciation rights payments (less amounts included in restructuring payments) 20.7 21.1 [1],[2] 46.0 [1]
Restructuring payments including associated costs 98.3 108.1 [1],[2] 107.0 [1]
Non-cash items:      
Transfers of shares of our common stock from treasury for our 2014, 2013, and 2012 profit-sharing plan contributions $ 36.7 33.2 [1],[2] $ 18.7 [1]
Transfer of shares of our common stock as part of the funding of the Settlement agreement [1],[2]   $ 1.8  
[1] For the years ended December 31, 2014 and 2013, certain amounts related to foreign currency gains and losses, including the remeasurement loss related to Venezuelan subsidiaries in 2014 and 2013, and the settlement of foreign currency forward contracts were misclassified. Additional revisions were made to the Consolidated Balance Sheets for the years ended December 31, 2014 and 2013. As a result, corresponding changes were made on the Consolidated Statement of Cash Flows. See Note 2 “Summary of Significant Accounting Policies and Recently Issued Accounting Standards” under the heading “Reclassifications and Revisions” for further discussion of the revisions.
[2] Interest payments in 2014 include $417 million related to the Settlement agreement
[3] The amounts do not include the expense related to our U.S. profit sharing contributions made in the form of our common stock as these contributions are not considered share-based incentive compensation.
[4] During the first quarter of 2015, the Company received the tax refund of $235 million related to the Settlement agreement payment. During the first quarter of 2014, we used $930 million of cash to fund the cash portion of the Settlement agreement and related accrued interest. We recorded an excess tax benefit of $46 million as an out of period adjustment in December 2015 and $38 million in December 2014 related to the 18 million shares of Common Stock issued in connection with the Settlement agreement. See Note 16 “Income Taxes” for further discussion of the out of period adjustment.
[5] As of December 31, 2015, we have adopted ASU 2015-17 which resulted in a decrease in deferred tax assets of $105.6 million, an increase in non-current deferred tax assets of $17.0 million, a decrease in current deferred tax liabilities of $4.8 million and a decrease in non-current deferred tax liabilities of $83.8 million as of December 31, 2014.
[6] During the fourth quarter of 2015, we completed the sale of our European food trays business. During the fourth quarter of 2015, the assets and liabilities met the criteria of held for sale classification. Accordingly, we reclassified $37 million of assets and $7 million of liabilities as held for sale as of December 31, 2014. Refer to Note 3, “Divestitures and Acquisitions” of the notes to Consolidated Financial Statements for further details. Certain foreign currency translation adjustments were misclassified within the components of Accumulated Other Comprehensive Income on the Consolidated Balance Sheets. Additionally, we reclassified $13 million from accounts payable to short-term borrowings related to extended payment terms on a vendor agreement and $36 million from cash to other assets related to cash used as collateral for borrowing agreements. See Note 2 “Summary of Significant Accounting Policies and Recently Issued Accounting Standards” under the heading “Reclassifications and Revisions” for further discussion of the revisions.
[7] During the second quarter of 2015, we completed the sale of our North American foam trays and absorbent pads business. During the first quarter of 2015, the assets and liabilities met the criteria of held for sale classification. Accordingly, we reclassified $42 million of assets and $6 million of liabilities as held for sale as of December 31, 2014. Refer to Note 3, “Divestitures and Acquisitions” of the notes to Consolidated Financial Statements for further details.